One Medical said the U.S. Federal Trade Commission had sought more information from the company and Amazon.com about the primary care provider’s $3.49-billion acquisition by the online retailer.
The request for new information is part of the U.S. anti-trust body’s review process, which is usually done to check if a deal has any anti-competitive consequences, Reuters reports.
Both parties plan to promptly respond to the request, One Medical said.
Analysts have said Amazon’s limited healthcare presence should minimize antitrust issues, but there were still risks, given the company faces scrutiny over its dominant tech position in the market. Read more.
